-
-
-
-
-
-
-
D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering
-
-
-
-
-
-
-
ImmunityBio (IBRX) Executes $40M Equity Financing with Institutional Investors
-
-
-
-
-
-
-
Form S-3/A ImmunityBio, Inc.
-
-
-
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

